BridgeMD
New treatment option for Primary Care
Official title Project CARE: CAncer Risk Evaluation
ClinicalTrials.gov ID: NCT07130487
What this study is testing
- What it's testing
- The purpose of Project CARE (cancer risk assessment and evaluation) research study is to explore the acceptance and feasibility of a study-initiated proactive outreach and digital care delivery model for conducting hereditary cancer risk assessment in primary care settings and facilitating genetic risk evaluation for patients flagged as high risk. Potential participants will be recruited from Rutgers Health primary care sites (family practice and general internal medicine).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Age 18 to 70 years
- Able to read and speak English
- Have an email address or mobile phone number in EPIC and/or are enrolled in MyChart
- Receiving health care in Family Medicine or General Internal Medicine at Rutgers Health within the past 2 years
- Have not opted out of receiving research-related communications
You likely can't join if
- Dementia (e.g., Alzheimer's disease) as indicated in EPIC
- Unable to access the Internet (via smartphone, tablet, or computer)
- Previous germline genetic testing for hereditary cancer risk
- Opted out of research participation in EPIC
- Have a personal history of cancer
See the full eligibility criteria
- Age 18 to 70 years
- Able to read and speak English
- Have an email address or mobile phone number in EPIC and/or are enrolled in MyChart
- Receiving health care in Family Medicine or General Internal Medicine at Rutgers Health within the past 2 years
- Have not opted out of receiving research-related communications
- Have internet access (via smartphone, tablet, or computer)
- Dementia (e.g., Alzheimer's disease) as indicated in EPIC
- Unable to access the Internet (via smartphone, tablet, or computer)
- Previous germline genetic testing for hereditary cancer risk
- Opted out of research participation in EPIC
- Have a personal history of cancer
The study team makes the final eligibility decision.
Where it's taking place
- New Brunswick, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Brunswick, New Jersey, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.